Wojciech Sulimierski, general manager of Aspen Poland and CEE, discusses the opening of the regional operations in 2014 and the importance of the CEE region as the company establishes itself in the global pharmaceutical ecosystem. Moreover, he highlights the impact of global acquisitions and the niche area model they have utilized to quickly gain an impressive market share in Poland as well as his aspirations for Aspen CEE in the future.
What have been your objectives since the Polish affiliate opened in 2014?
"In Europe, our business model is focused on classical brands and targeted promotion to specialists; a good example having the thrombosis business as one our specialist operations."
